|
Market Cap | 845.01M | EPS (ttm) | -2.13 |
P/E | - | EPS this Y | 24.26% |
Forward P/E | - | EPS next Y | 8.76% |
PEG | - | EPS past 5Y | -193.88% |
P/S | 1432.22 | EPS next 5Y | - |
P/B | 3.47 | EPS Q/Q | 0.97% |
Dividend | - | Sales Q/Q | - |
Insider Own | 58.50% | Inst Own | 34.66% |
Insider Trans | 15.84% | Inst Trans | - |
Short Float | 21.84% | Earnings | May 10/b |
Analyst Recom | 1.36 | Target Price | 14.60 |
Avg Volume | 717.54K | 52W Range | 4.11 - 17.20 |
|
|
May-16-24 | Upgrade |
Citigroup |
Neutral → Buy |
$10 |
|
|
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
NELSEN ROBERT | Director | Feb 15 '24 | Buy | 6.25 | 3,200,000 | 20,000,000 | 3,200,000 | Feb 20 05:41 PM | ARCH Venture Partners X, LLC | 10% Owner | Feb 15 '24 | Buy | 6.25 | 3,200,000 | 20,000,000 | 3,200,000 | Feb 20 05:37 PM | ARCH Venture Partners XII, LLC | 10% Owner | Feb 15 '24 | Buy | 6.25 | 3,200,000 | 20,000,000 | 3,200,000 | Feb 20 05:38 PM | GV 2019 GP, L.L.C. | 10% Owner | Jun 21 '23 | Sale | 14.97 | 19,003 | 284,496 | 0 | Jun 22 05:03 PM | GV 2019 GP, L.L.C. | 10% Owner | Jun 20 '23 | Sale | 15.06 | 37,405 | 563,248 | 0 | Jun 22 05:03 PM |
|
|
|
|
Market Cap | 1.38B | EPS (ttm) | -0.64 |
P/E | - | EPS this Y | 59.13% |
Forward P/E | - | EPS next Y | 99.62% |
PEG | - | EPS past 5Y | -106.11% |
P/S | 1.19 | EPS next 5Y | - |
P/B | 4.54 | EPS Q/Q | 72.88% |
Dividend | - | Sales Q/Q | 19.43% |
Insider Own | 25.97% | Inst Own | 95.69% |
Insider Trans | 0.06% | Inst Trans | 4.90% |
Short Float | 39.82% | Earnings | May 02/a |
Analyst Recom | 2.33 | Target Price | 32.00 |
Avg Volume | 788.64K | 52W Range | 18.45 - 36.66 |
|
|
May-16-24 | Upgrade |
BofA Securities |
Neutral → Buy |
$35 → $49 |
|
|
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
RAWLINGS DARRYL | Chief Executive Officer | May 07 '24 | Buy | 24.14 | 20,700 | 499,663 | 614,842 | May 09 06:40 PM | DREYER EMILY | SVP, Channel Growth | May 07 '24 | Sale | 25.34 | 3,125 | 79,201 | 19,830 | May 09 05:56 PM | RUBIN HOWARD E | Director | Mar 31 '24 | Option Exercise | 0.00 | 569 | 0 | 229,405 | Apr 03 07:20 PM | LEVITAN DAN | Director | Mar 31 '24 | Option Exercise | 0.00 | 1,582 | 0 | 95,116 | Apr 03 07:20 PM | Satchu Zay | Director | Mar 31 '24 | Option Exercise | 0.00 | 1,582 | 0 | 4,788 | Apr 03 07:20 PM |
|
|
|
|
Market Cap | 7.62B | EPS (ttm) | -0.93 |
P/E | - | EPS this Y | -21.98% |
Forward P/E | - | EPS next Y | -38.65% |
PEG | - | EPS past 5Y | -18.89% |
P/S | - | EPS next 5Y | 40.00% |
P/B | 8.15 | EPS Q/Q | -6.06% |
Dividend | - | Sales Q/Q | - |
Insider Own | 8.05% | Inst Own | 72.67% |
Insider Trans | -8.76% | Inst Trans | -0.29% |
Short Float | 11.94% | Earnings | Apr 24/a |
Analyst Recom | 1.00 | Target Price | 112.35 |
Avg Volume | 6.34M | 52W Range | 8.28 - 99.41 |
|
|
May-16-24 | Upgrade |
Raymond James |
Outperform → Strong Buy |
$115 → $116 |
|
|
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ZANTE GREG | Chief Financial Officer | May 03 '24 | Option Exercise | 4.86 | 34,249 | 166,285 | 241,610 | May 03 08:51 PM | ZANTE GREG | Chief Financial Officer | May 03 '24 | Sale | 74.69 | 66,756 | 4,986,008 | 174,854 | May 03 08:51 PM | Mancini Marianna | Chief Operating Officer | May 01 '24 | Option Exercise | 6.18 | 281,425 | 1,740,575 | 629,933 | May 02 09:27 PM | Mancini Marianna | Chief Operating Officer | May 01 '24 | Sale | 78.66 | 281,425 | 22,136,474 | 348,508 | May 02 09:27 PM | Lian Brian | President & CEO | Feb 09 '24 | Sale | 29.90 | 45,000 | 1,345,500 | 2,139,882 | Feb 09 08:59 PM |
|
|
| |
|
Market Cap | 8.37B | EPS (ttm) | -5.36 |
P/E | - | EPS this Y | 201.26% |
Forward P/E | 31.88 | EPS next Y | 88.24% |
PEG | - | EPS past 5Y | -2.82% |
P/S | 0.70 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 35.96% |
Dividend | - | Sales Q/Q | -1.62% |
Insider Own | 28.31% | Inst Own | 88.06% |
Insider Trans | -0.78% | Inst Trans | -1.42% |
Short Float | 21.79% | Earnings | May 02/b |
Analyst Recom | 1.92 | Target Price | 71.80 |
Avg Volume | 4.58M | 52W Range | 33.85 - 90.71 |
|
|
May-16-24 | Upgrade |
Argus |
Hold → Buy |
|
|
|
Wayfair, Inc. engages in an online home furnishing store. It operates through the U.S. and International segments. The U.S. segment consists of amounts earned through product sales through the company's five distinct sites in the U.S. and through websites operated by third parties in the U.S. The International segment is composed of earnings through product sales in international sites. The company was founded by Steven K. Conine and Niraj S. Shah in May 2002 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Conine Steven | Co-Founder | May 07 '24 | Sale | 68.26 | 10,000 | 682,588 | 229,073 | May 08 06:54 PM | Shah Niraj | Chief Executive Officer | May 07 '24 | Sale | 68.03 | 10,000 | 680,330 | 229,137 | May 08 06:50 PM | Schaferkordt Anke | Director | May 02 '24 | Sale | 58.81 | 348 | 20,465 | 13,251 | May 03 05:24 PM | Blotner Jon | Chief Commercial Officer | Apr 15 '24 | Sale | 60.52 | 4,144 | 250,795 | 37,957 | Apr 16 08:01 PM | Conine Steven | Co-Founder | Apr 08 '24 | Sale | 64.62 | 10,000 | 646,182 | 239,073 | Apr 09 08:29 PM |
|
|
|
|
Market Cap | 463.38M | EPS (ttm) | -13.73 |
P/E | - | EPS this Y | 168.18% |
Forward P/E | 22.95 | EPS next Y | 25.42% |
PEG | - | EPS past 5Y | 3.36% |
P/S | 0.70 | EPS next 5Y | 64.40% |
P/B | 1.19 | EPS Q/Q | 74.93% |
Dividend | - | Sales Q/Q | -47.57% |
Insider Own | 3.07% | Inst Own | 89.92% |
Insider Trans | 0.00% | Inst Trans | -0.42% |
Short Float | 3.05% | Earnings | May 08/a |
Analyst Recom | 3.00 | Target Price | 18.00 |
Avg Volume | 335.94K | 52W Range | 6.52 - 20.91 |
|
|
May-16-24 | Upgrade |
Needham |
Hold → Buy |
$20 |
|
|
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and Dental Products segments. The Spine Products segment offers spinal surgery solutions such as implants, instrumentation, biologics, and bone healing technologies to treat patients with back or neck pain caused by degenerative conditions, deformities, tumors or traumatic injury of the spine. The Dental Products segment provides dental implant solutions, biomaterial solutions, and digital dentistry. The company was founded on November 4, 2021 and is headquartered in Palm Beach Gardens, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Jamali Vafa | See remarks below. | Apr 01 '24 | Option Exercise | 0.00 | 21,331 | 0 | 259,924 | Apr 03 04:04 PM | Whitney Rebecca Ann | See remarks below. | Mar 29 '24 | Option Exercise | 0.00 | 9,677 | 0 | 42,706 | Apr 02 04:01 PM | Schneider Sandra | Chief Accounting Officer | Mar 10 '24 | Option Exercise | 0.00 | 3,591 | 0 | 17,474 | Mar 11 05:31 PM | Whitney Rebecca Ann | See remarks below. | Mar 10 '24 | Option Exercise | 0.00 | 4,163 | 0 | 34,226 | Mar 11 05:30 PM | Kidwell Heather | See remarks below. | Mar 10 '24 | Option Exercise | 0.00 | 2,776 | 0 | 60,046 | Mar 11 05:32 PM |
|
|
|
|